Prospects of antisense oligodeoxynucleotides to alleviate renal ischaemia–reperfusion injury

Bibliography

• OJO AO, WOLFE RA, HELD PJ,PORT FK, SCHMOUDER RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 63(7):968–974.
   PubMed Web of Science ®Google Scholar
• TOMITA N, MORISHITA R: Antisenseoligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases. Carr: Pliarin. Des. (2004) 10(7):797–803.
   PubMed Web of Science ®Google Scholar
• •An original article on AS-ODNs as a useful therapy for cardiovascular disease.
   Google Scholar
• CROOKE ST: Antisense strategies.Carr. Ma Med. (2004) 4(5):465–487.
   Google Scholar
• •A thorough review of AS-ODNs.
   Google Scholar
• PHILLIPS MI, GALLI SM, MEHTA JL:The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease. Drugs (2000) 60(2):239–248.
   PubMed Web of Science ®Google Scholar
• •An original article on AS-ODNs as a useful therapy for cardiovascular disease.
   Google Scholar
• MATSUYAMA M, YOSHIMURA R,AKIOKA K et al.: Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation (2003) 76(5):786–791.
   Google Scholar
• ••An original article on antisense-TF asuseful for the inhibition of renal FR injury.
   Google Scholar
• DRAGUN D, TULLIUS SG, HALLER H et al: ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int. (1998) 54(2):590–602.
   PubMed Web of Science ®Google Scholar
• ••An original article on antisense-ICAM-1 asuseful for the inhibition of renal I/R injury.
   Google Scholar
• NAKA Y, ROY DK, SMERLING AJ et al.: Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. Thome. Cardiovasc. Surg. (1995) 110(5):1434–1440.
   Web of Science ®Google Scholar
• CHANG SW, WESTCOTT JY, PICKETT WC, MURPHY RC, VOELKEL NF: Endotwdn-induced lung injury in rats: role of eicosanoids. Appl. Physic] (1989) 66(5):2407–2418.
   PubMed Web of Science ®Google Scholar
• KEAN JM, MURAKAMI A, BLAKE KR, CUSHMAN CD, MILLER PS: Photochemical cross-linking of psoralen-derivatized oligonucleoside methylphosphonates to rabbit globin messenger RNA. Biochemistry (1988) 27(26):9113–9121.
   PubMed Web of Science ®Google Scholar
• SLOOP KW, CAO JX, SIESKY AM et al.: Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J. Clin. Invest. (2004) 113(11):1571–1581.
   PubMed Web of Science ®Google Scholar
• HAYWARD RL, MACPHERSON JS, CUMMINGS J, MONIA BP, SMYTH JF, JODRELL DI: Enhanced oxaliplatin-induced apoptosis following antisense Bc1-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect. MM. Cancer Ther: (2004) 3(2):169–178.
   PubMed Web of Science ®Google Scholar
• YU RZ, GEARY RS, MONTEITH DK et al: Tissue disposition of 2'-0-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys. Pharin. Sci. (2004) 93(1):48–59.
   PubMed Web of Science ®Google Scholar
• TOMITA N, OGIHARA T,MORISHITA R: Therapeutic potential of decoy oligodeoxynucleotides strategy in cardiovascular diseases. Expert Rev Cardiovasc. Ther. (2003) 1(3):463–470.
   PubMedGoogle Scholar
• •An original article on the transfer of cis-element double-stranded ODN as a useful therapy for cardiovascular disease.
   Google Scholar
• MORISHITA R, TOMITA N,KANEDA Y, OGIHARA T: Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Carr. Opin. Pharinacol (2004) 4(2):139–146.
   PubMed Web of Science ®Google Scholar
• •A thorough review on the transfer of cis-element double-stranded ODNs.
   Google Scholar
• KOBAYASHI Y, YOSHIMURA N, NAKAMURA K, YAMAGISHI H, OKA T: Expression of tissue factor in hepatic ischemic-reperfusion injury of the rat. Transplantation (1998) 66(6):708–716.
   PubMed Web of Science ®Google Scholar
• YOSHIMURA N, KOBAYASHI Y, NAKAMURA K, YAMAGISHI H, OKA T: The effect of tissue factor pathway inhibitor on hepatic ischemic reperfusion injury of the rat. Transplantation (1999) 67(1):45–53.
   PubMed Web of Science ®Google Scholar
• USHIGOME H, YOSHIMURA N, SANO H, NAKAMURA K, OKA T: Expression of tissue factor in renal ischemic-reperfusion injury of the rat. Transplant. Proc. (1998) 30(7):3764–3765.
   PubMed Web of Science ®Google Scholar
• NAKAMURA K, OKAMOTO M, AKIOKA K et al.: Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury.Transplant. Proc. (2001) 33(7–8):3707–3708.
   Google Scholar
• USHIGOME H, SANO H,OKAMOTO M et al.: The role of tissue factor in renal ischemic reperfusion injury of the rat. J. Sorg. Res. (2002) 102:102–109.
   Google Scholar
• MATSUYAMA M, AKIOKA K, OKAMOTO M et al.: The role of tissue factor in renal ischemic reperfusion injury by antisense oligonucleotide. Transplant. Proc. (2002) 34(5):1475–1476.
   PubMed Web of Science ®Google Scholar
• MATSUYAMA M, AKIOKA K, OKAMOTO M et al.: Control of renal ischemic reperfusion injury by antisense oligodeoxynucleotide of tissue factor. Transplant. Proc. (2003) 35(1):103–104.
   PubMed Web of Science ®Google Scholar
• NAKAMURA K, KADOTANI Y, USHIGOME H et al.: Antisense oligonucleotide for tissue factor inhibits hepatic ischemic reperfusion injury. Biochein. Biophys. Res. Commun. (2002) 297(3):433–441.
   PubMed Web of Science ®Google Scholar
• •An original article on antisense-TF as useful for the inhibition of hepatic I/R injury.
   Google Scholar
• STEPKOWSKI SM, WANG ME, CONDON TP et al: Protection against allograft rejection with intercellular adhesion molecule-1 antisense E-selectin and ICAM-1 induces endothelial tissuefactor production via autocrine secretion of platelet oligodeoxynucleotides. Transplantation (1998) 66(6): 699–707.
   PubMed Web of Science ®Google Scholar
• •An original article on AS-ODNs as a useful therapy for renal transplantation.
   Google Scholar
• STEPKOWSKI SM: Development ofantisense oligodeoxynucleotides fortransplantation. Carr. Opin. Mol. Thec (2000) 2(3):304–317.
   PubMedGoogle Scholar
• •A thorough review on AS-ODNs as a useful therapy for renal transplantation.
   Google Scholar
• SCHMID E, MULLER TH, BUDZINSKI RM, BINDER K, PFIZENMAIER K: Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J. Interferon Cytokine Res. (1995) 15(9):819–825.
   PubMed Web of Science ®Google Scholar
• KELLY KJ, WILLIAMS WW,COLVIN RB et al.: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. j Clin. Invest. (1996) 97(4):1056–1063.
   Google Scholar
• KELLY KJ, WILLIAMS WW,COLVIN RB, BONVENTRE JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA (1994) 91(2):812–816.
   PubMed Web of Science ®Google Scholar
• LOPEZ-NEBLINA F, PAEZ-ROLLYS AJ, TOLEDO-PEREYRA LH: Mechanism of protection of verapamil by preventing neutrophil infiltration in the ischemic rat kidney." Surg. Res. (1996) 61(2):469–472.
   Google Scholar
• BANAFSCHE R, GUNTHER L, NEFFLEN JU et al.: NF-kappa B antisense oligonucleotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperfusion. Transplant. Proc. (2001) 33(7-8):3726–3727.
   PubMed Web of Science ®Google Scholar
• TAKEYOSHI I, SUNOSE Y, IWAZAKI S et al.: The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs. I Sorg. Res. (2001) 100(1):25–31.
   PubMed Web of Science ®Google Scholar
• SUNOSE Y, TAKEYOSHI I,TSUTSUMI H et al.: Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. " Surg. Res. (2001) 95(2):167–173.
   Google Scholar
• MATSUYAMA M, NAKATANI T, KAWAHITO Y et al: The expression of cyclooxygenases (COXs) and lipoxygenases (LOXs) in renal ischemia-reperfusion injury. Transplant. Proc. (2004) 36(7):1939–1942.
   PubMed Web of Science ®Google Scholar
• YAMADA R, SANO H, HLA T et al.: Selective inhibition of cyclooxygenase-2 with antisense ofigodeoxynucleotide restricts induction of rat adjuvant-induced arthritis. Biochem. Biophys. Res. Commun. (2000) 269(2):415–421.
   PubMed Web of Science ®Google Scholar
• HASHIMOTO H, MIYAZAWA K, HAGIWARA M, MIYASAKA K, NAKASHIMA M: Benefical effects of a 5-lipoxygenase inhibitor on occlusion-and occlusion-reperfusion-induced myocardial injury. Arzneimittelforshung (1990) 40(2):126–129.
   PubMed Web of Science ®Google Scholar
• SHISHIDO Y, FURUSHIRO M, HASHIMOTO S, YOKOKURA T: Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia. Pharmacol Biochem. Behav. (2001) 69(3-4):469–474.
   PubMed Web of Science ®Google Scholar
• PATEL NS, CUZZOCREA S, CHATTERJEE PK et al.: Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.Pharmacol (2004) 66(2):220–227.
   Web of Science ®Google Scholar